U.S. hospitalizations for pneumonia after a decade of pneumococcal vaccination.
about
Multistate outbreak of respiratory infections among unaccompanied children, June-July 2014A Review of Pneumococcal Vaccines: Current Polysaccharide Vaccine Recommendations and Future Protein AntigensThe role of respiratory viruses in the etiology of bacterial pneumonia: An ecological perspectiveDatabase Research for Pediatric Infectious DiseasesGlobal, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.Impacts of the 13-Valent Pneumococcal Conjugate Vaccine in ChildrenPneumococcal serotype evolution in Western EuropeImpact of pneumococcal conjugate vaccination: a retrospective study of hospitalization for pneumonia in North-East ItalyPrevention of Community-Acquired Pneumonia with Available Pneumococcal VaccinesEpidemiology, virulence factors and management of the pneumococcusCardiotoxicity during invasive pneumococcal diseaseA current and historical perspective on disparities in US childhood pneumococcal conjugate vaccine adherence and in rates of invasive pneumococcal disease: Considerations for the routinely-recommended, pediatric PCV dosing schedule in the United StaPneumococcal Disease in the Era of Pneumococcal Conjugate VaccineRespiratory risks from household air pollution in low and middle income countriesPneumococcal Vaccination Guidance for Post-Acute and Long-Term Care Settings: Recommendations From AMDA's Infection Advisory Committee.Estimating the population-level impact of vaccines using synthetic controls.Appropriateness of administrative data for vaccine impact evaluation: the case of pneumonia hospitalizations and pneumococcal vaccine in Brazil.Using Pneumococcal Carriage Data to Monitor Postvaccination Changes in the Incidence of Pneumococcal Otitis Media.Challenges to estimating vaccine impact using hospitalization data.Development of evidence-based Australian medication-related indicators of potentially preventable hospitalisations: a modified RAND appropriateness methodInfluence of Antibiotics on the Detection of Bacteria by Culture-Based and Culture-Independent Diagnostic Tests in Patients Hospitalized With Community-Acquired PneumoniaImpact of pneumococcal conjugate vaccines on the incidence of pneumonia in hospitalized children after five years of its introduction in Uruguay.Antibiotic Prescribing for Adults Hospitalized in the Etiology of Pneumonia in the Community StudyInvasive pneumococcal disease in children can reveal a primary immunodeficiency.A population-based study on the impact of hospitalization for pneumonia in different age groups.All-cause pneumonia hospitalizations in children <2 years old in sweden, 1998 to 2012: impact of pneumococcal conjugate vaccine introduction.Rates of pneumococcal disease in adults with chronic medical conditions.Trends in pathogens among patients hospitalized for pneumonia from 1993 to 2011.Nutritional status of children hospitalized for parapneumonic effusionDynamics of lung defense in pneumonia: resistance, resilience, and remodeling.A cluster-randomized controlled trial of a multicomponent intervention protocol for pneumonia prevention among nursing home eldersThe serotype distribution among healthy carriers before vaccination is essential for predicting the impact of pneumococcal conjugate vaccine on invasive disease.Using Standardized Interpretation of Chest Radiographs to Identify Adults with Bacterial Pneumonia--Guatemala, 2007-2012.Pneumococcal nasopharyngeal carriage in children <5 years of age visiting the pediatric emergency room in relation to PCV7 and PCV13 introduction in southern IsraelIncidence of Hospitalized Pneumococcal Pneumonia among Adults in Guatemala, 2008-2012.Rates of pneumonia among children and adults with chronic medical conditions in Germany.The impact of primary care on emergency department presentation and hospital admission with pneumonia: a case-control study of preschool-aged childrenSafety and tolerability of 13-valent pneumococcal conjugate vaccine in the elderly.Immunological Features and Clinical Benefits of Conjugate Vaccines against Bacteria.Infectious Disease-related Emergency Department Visits Among Children in the US
P2860
Q23921099-6F5E6948-F69B-4BED-8DDC-3688B0AF645EQ26753152-CB589591-AE85-4540-8C0E-6E480E668BBCQ26765407-6EEEA10F-58FB-48E4-9D78-C05D46BDB268Q26781065-135CAC87-FA52-468B-9440-F507F6EEC9CFQ26782024-DF5805B7-9457-4336-AA52-90C46949CDBFQ26782280-BE8C1868-8AF0-4A29-B5A7-BF0B0F46912CQ26782963-4728988B-436A-42C9-A310-62C8DD3AEB90Q28075109-AB81DF2D-36CF-488A-8314-B78E6B0639E3Q28077703-0D93F1EB-B8C2-4EB6-A95E-81A911BA0B43Q28078832-ED247D22-A1E0-4780-B078-6F7BA491E949Q28081769-14D47C77-4E9E-4E69-AA25-A337F11F5FB5Q28085452-9F401438-C1C7-48CD-8132-65AA203F7A4AQ28088610-BEEAD16A-2478-4588-B8F8-4C77D23395D0Q28391847-7C864E61-5CE8-43E5-B5E5-32B9C67E9D16Q30274913-F415CFA7-D87B-4EC6-BDFC-08319E0CF0FCQ30398164-09D0010A-0D8A-4986-B916-9B0D79484E2AQ30807600-BC6C1452-A711-4653-8BA3-49D4A326DB40Q31136900-89B5F72B-3F11-400A-B245-96C1A955F1F4Q31145427-ACF938BA-33BA-42E8-9F90-FE493423F2C9Q33569589-1AAE4BB2-9F48-41F8-8047-5AD3D6F072F6Q33629579-064BF300-8F71-440A-9A45-360F5C339FB1Q33721240-10249556-A43A-45B7-9D48-6CA21ECAC3A8Q33904263-FB21BC59-4B14-4450-8534-4C414906158EQ33917973-4321C786-BD8E-4748-B108-79D5CE683630Q34184995-09440361-0D54-4D1A-918B-7BFD902DEA6FQ34473127-D1AD96BC-955E-4EFF-B7FF-2CCC4F331CBFQ35071933-4C521A65-6D92-41A5-B2FB-3AA7803EBDE2Q35087078-152B4C0D-80CA-439B-8871-3FB29204C9BEQ35140253-C6700C98-298F-42FA-8112-52BDFCFEBE6BQ35196768-1CF4F110-E4C6-490C-8570-9BDF47F33A7DQ35555252-0ACE40C4-B53E-472B-961D-BFE8238C21E2Q35603351-3A43207D-EE0B-4224-ABE4-6FE5F1E98E0AQ35711247-8BD65597-9960-4A8E-944D-9BBBEB7501C6Q35796784-E6EBD7A1-2271-4E01-BC8D-B1BF16BA0657Q35816192-8D4822FD-F9CC-4AA4-9563-9D73610592D1Q35826671-E88E5555-69D5-4F8D-86C7-EA52BF7C2471Q35837410-5F22EBC1-2FCB-40AE-8813-7F31486AAD2DQ35886979-E341D3B0-ECCB-48AC-9007-E4DC246CCCA3Q36016022-BD4065AF-DFE9-478A-94D8-B13B0DCD3E74Q36047295-BAA001E5-0712-4429-94C0-86DAC681003B
P2860
U.S. hospitalizations for pneumonia after a decade of pneumococcal vaccination.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
U.S. hospitalizations for pneumonia after a decade of pneumococcal vaccination.
@en
type
label
U.S. hospitalizations for pneumonia after a decade of pneumococcal vaccination.
@en
prefLabel
U.S. hospitalizations for pneumonia after a decade of pneumococcal vaccination.
@en
P2093
P2860
P356
P1476
U.S. hospitalizations for pneumonia after a decade of pneumococcal vaccination.
@en
P2093
Carlos G Grijalva
Cynthia G Whitney
Marie R Griffin
Matthew R Moore
P2860
P304
P356
10.1056/NEJMOA1209165
P407
P577
2013-07-01T00:00:00Z